ERAS: Improving outcome in the cachectic HPB patient

David P. J. van Dijk; Victor van Woerden; Hamit Cakir; Marcel den Dulk; Steven W. M. Olde Damink; Cornelis H. C. Dejong

doi:10.1002/jso.24767

ERAS: Improving outcome in the cachectic HPB patient

David P. J. van Dijk^*, Victor van Woerden, Hamit Cakir, Marcel den Dulk, Steven W. M. Olde Damink, Cornelis H. C. Dejong

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

10 Citations (Web of Science)

Abstract

The enhanced recovery after surgery (ERAS) program has reduced postoperative morbidity and duration of hospital stay but not mortality in patients undergoing hepatopancreatobiliary (HPB) surgery. Many HPB patients suffer from cancer cachexia, a syndrome of severe weight and muscle loss. This may affect outcomes of HPB surgery even within an ERAS program. A tailored ERAS approach may be essential in further improving outcome in this vulnerable patient category.

Original language	English
Pages (from-to)	617-622
Number of pages	6
Journal	Journal of Surgical Oncology
Volume	116
Issue number	5
DOIs	https://doi.org/10.1002/jso.24767
Publication status	Published - 1 Oct 2017

Keywords

body composition
cancer cachexia
enhanced recovery after surgery
hepatopancreatobiliary surgery
outcome
COLORECTAL LIVER METASTASES
RANDOMIZED CONTROLLED-TRIALS
INTERNATIONAL STUDY-GROUP
C-REACTIVE PROTEIN
PANCREATIC EXOCRINE INSUFFICIENCY
MUSCLE RADIATION ATTENUATION
ADIPOSE-TISSUE CONTENT
ACUTE-PHASE RESPONSE
COMPOSITE END-POINT
ENHANCED RECOVERY

Access to Document

10.1002/jso.24767

Cite this

@article{4ed2c1e2457a41b89ca44ae6ef7fadf5,

title = "ERAS: Improving outcome in the cachectic HPB patient",

abstract = "The enhanced recovery after surgery (ERAS) program has reduced postoperative morbidity and duration of hospital stay but not mortality in patients undergoing hepatopancreatobiliary (HPB) surgery. Many HPB patients suffer from cancer cachexia, a syndrome of severe weight and muscle loss. This may affect outcomes of HPB surgery even within an ERAS program. A tailored ERAS approach may be essential in further improving outcome in this vulnerable patient category.",

keywords = "body composition, cancer cachexia, enhanced recovery after surgery, hepatopancreatobiliary surgery, outcome, COLORECTAL LIVER METASTASES, RANDOMIZED CONTROLLED-TRIALS, INTERNATIONAL STUDY-GROUP, C-REACTIVE PROTEIN, PANCREATIC EXOCRINE INSUFFICIENCY, MUSCLE RADIATION ATTENUATION, ADIPOSE-TISSUE CONTENT, ACUTE-PHASE RESPONSE, COMPOSITE END-POINT, ENHANCED RECOVERY",

author = "{van Dijk}, {David P. J.} and {van Woerden}, Victor and Hamit Cakir and {den Dulk}, Marcel and Damink, {Steven W. M. Olde} and Dejong, {Cornelis H. C.}",

year = "2017",

month = oct,

day = "1",

doi = "10.1002/jso.24767",

language = "English",

volume = "116",

pages = "617--622",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - ERAS

T2 - Improving outcome in the cachectic HPB patient

AU - van Dijk, David P. J.

AU - van Woerden, Victor

AU - Cakir, Hamit

AU - den Dulk, Marcel

AU - Damink, Steven W. M. Olde

AU - Dejong, Cornelis H. C.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The enhanced recovery after surgery (ERAS) program has reduced postoperative morbidity and duration of hospital stay but not mortality in patients undergoing hepatopancreatobiliary (HPB) surgery. Many HPB patients suffer from cancer cachexia, a syndrome of severe weight and muscle loss. This may affect outcomes of HPB surgery even within an ERAS program. A tailored ERAS approach may be essential in further improving outcome in this vulnerable patient category.

AB - The enhanced recovery after surgery (ERAS) program has reduced postoperative morbidity and duration of hospital stay but not mortality in patients undergoing hepatopancreatobiliary (HPB) surgery. Many HPB patients suffer from cancer cachexia, a syndrome of severe weight and muscle loss. This may affect outcomes of HPB surgery even within an ERAS program. A tailored ERAS approach may be essential in further improving outcome in this vulnerable patient category.

KW - body composition

KW - cancer cachexia

KW - enhanced recovery after surgery

KW - hepatopancreatobiliary surgery

KW - outcome

KW - COLORECTAL LIVER METASTASES

KW - RANDOMIZED CONTROLLED-TRIALS

KW - INTERNATIONAL STUDY-GROUP

KW - C-REACTIVE PROTEIN

KW - PANCREATIC EXOCRINE INSUFFICIENCY

KW - MUSCLE RADIATION ATTENUATION

KW - ADIPOSE-TISSUE CONTENT

KW - ACUTE-PHASE RESPONSE

KW - COMPOSITE END-POINT

KW - ENHANCED RECOVERY

U2 - 10.1002/jso.24767

DO - 10.1002/jso.24767

M3 - Review article

C2 - 28767125

VL - 116

SP - 617

EP - 622

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 5

ER -